HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-OCT-16 5TR6 TITLE DISCOVERY OF TAK-659, AN ORALLY AVAILABLE INVESTIGATIONAL INHIBITOR OF TITLE 2 SPLEEN TYROSINE KINASE (SYK) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 356-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9 KEYWDS INHIBITOR, KINASE, LEUKEMIA, LYMPHOMA, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.YANO,A.JENNINGS,B.LAM,I.D.HOFFMAN REVDAT 4 06-MAR-24 5TR6 1 REMARK REVDAT 3 22-NOV-17 5TR6 1 REMARK REVDAT 2 14-DEC-16 5TR6 1 JRNL REVDAT 1 30-NOV-16 5TR6 0 JRNL AUTH B.LAM,Y.ARIKAWA,J.CRAMLETT,Q.DONG,R.DE JONG,V.FEHER, JRNL AUTH 2 C.E.GRIMSHAW,P.J.FARRELL,I.D.HOFFMAN,A.JENNINGS,B.JONES, JRNL AUTH 3 J.MATUSZKIEWICZ,J.MIURA,H.MIYAKE,S.R.NATALA,L.SHI, JRNL AUTH 4 M.TAKAHASHI,E.TAYLOR,C.WYRICK,J.YANO,J.ZALEVSKY,Z.NIE JRNL TITL DISCOVERY OF TAK-659 AN ORALLY AVAILABLE INVESTIGATIONAL JRNL TITL 2 INHIBITOR OF SPLEEN TYROSINE KINASE (SYK). JRNL REF BIOORG. MED. CHEM. LETT. V. 26 5947 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27839918 JRNL DOI 10.1016/J.BMCL.2016.10.087 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 22613 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1204 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1563 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2217 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 132 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.40000 REMARK 3 B22 (A**2) : -2.25000 REMARK 3 B33 (A**2) : 2.66000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.163 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.139 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.112 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.927 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2314 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2174 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3127 ; 1.121 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5006 ; 0.850 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 276 ; 5.522 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 109 ;38.019 ;24.037 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 413 ;11.990 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;18.726 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 325 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2587 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 542 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1092 ; 0.959 ; 1.930 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1091 ; 0.960 ; 1.928 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1363 ; 1.672 ; 2.884 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 362 A 639 REMARK 3 RESIDUE RANGE : A 701 A 702 REMARK 3 RESIDUE RANGE : A 801 A 932 REMARK 3 ORIGIN FOR THE GROUP (A): -3.887 -10.474 19.991 REMARK 3 T TENSOR REMARK 3 T11: 0.0118 T22: 0.0943 REMARK 3 T33: 0.0082 T12: -0.0059 REMARK 3 T13: -0.0031 T23: -0.0137 REMARK 3 L TENSOR REMARK 3 L11: 1.8748 L22: 3.5915 REMARK 3 L33: 1.0638 L12: -0.5311 REMARK 3 L13: 0.5240 L23: -0.1033 REMARK 3 S TENSOR REMARK 3 S11: -0.0151 S12: 0.0117 S13: 0.0422 REMARK 3 S21: -0.1430 S22: 0.0160 S23: 0.1111 REMARK 3 S31: -0.0705 S32: -0.0524 S33: -0.0009 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5TR6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-16. REMARK 100 THE DEPOSITION ID IS D_1000224691. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9764848 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL, CYLINDRICALLY REMARK 200 BENT, SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22613 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.7M POTASSIUM NA TARTRATE, 0.06M REMARK 280 MES_NA, 0.04M MES, PH 6.1, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.97050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.14150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.64150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.14150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.97050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.64150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 LYS A 405 REMARK 465 ASN A 406 REMARK 465 GLU A 407 REMARK 465 ALA A 408 REMARK 465 ASN A 409 REMARK 465 ASP A 410 REMARK 465 HIS A 640 REMARK 465 HIS A 641 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 402 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 393 -55.18 -13.22 REMARK 500 LYS A 394 -53.60 -149.44 REMARK 500 ALA A 441 -132.06 -129.90 REMARK 500 ASP A 494 43.27 -159.36 REMARK 500 ASP A 512 74.11 59.87 REMARK 500 TRP A 609 34.59 -90.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7KG A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TT7 RELATED DB: PDB DBREF 5TR6 A 356 635 UNP P43405 KSYK_HUMAN 356 635 SEQADV 5TR6 MET A 353 UNP P43405 INITIATING METHIONINE SEQADV 5TR6 ALA A 354 UNP P43405 EXPRESSION TAG SEQADV 5TR6 LEU A 355 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 636 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 637 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 638 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 639 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 640 UNP P43405 EXPRESSION TAG SEQADV 5TR6 HIS A 641 UNP P43405 EXPRESSION TAG SEQRES 1 A 289 MET ALA LEU GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU SEQRES 2 A 289 ASP ARG LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SEQRES 3 A 289 SER GLY ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN SEQRES 4 A 289 MET LYS LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU SEQRES 5 A 289 LYS ASN GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU SEQRES 6 A 289 LEU ALA GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO SEQRES 7 A 289 TYR ILE VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER SEQRES 8 A 289 TRP MET LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU SEQRES 9 A 289 ASN LYS TYR LEU GLN GLN ASN ARG HIS VAL LYS ASP LYS SEQRES 10 A 289 ASN ILE ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET SEQRES 11 A 289 LYS TYR LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU SEQRES 12 A 289 ALA ALA ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA SEQRES 13 A 289 LYS ILE SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA SEQRES 14 A 289 ASP GLU ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP SEQRES 15 A 289 PRO VAL LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR SEQRES 16 A 289 LYS PHE SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 289 LEU MET TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR SEQRES 18 A 289 ARG GLY MET LYS GLY SER GLU VAL THR ALA MET LEU GLU SEQRES 19 A 289 LYS GLY GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG SEQRES 20 A 289 GLU MET TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP SEQRES 21 A 289 VAL GLU ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG SEQRES 22 A 289 LEU ARG ASN TYR TYR TYR ASP VAL VAL ASN HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS HET 7KG A 701 25 HET EDO A 702 4 HETNAM 7KG 6-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-7-FLUORO-4-(1- HETNAM 2 7KG METHYL-1H-PYRAZOL-4-YL)-1,2-DIHYDRO-3H-PYRROLO[3,4- HETNAM 3 7KG C]PYRIDIN-3-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 7KG C17 H21 F N6 O FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *132(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ALA A 412 LEU A 427 1 16 HELIX 3 AA3 LEU A 456 ASN A 463 1 8 HELIX 4 AA4 LYS A 467 SER A 488 1 22 HELIX 5 AA5 ALA A 496 ARG A 498 5 3 HELIX 6 AA6 PRO A 535 TYR A 539 5 5 HELIX 7 AA7 ALA A 540 TYR A 547 1 8 HELIX 8 AA8 SER A 550 SER A 567 1 18 HELIX 9 AA9 LYS A 577 LYS A 587 1 11 HELIX 10 AB1 PRO A 598 TRP A 609 1 12 HELIX 11 AB2 GLY A 618 HIS A 639 1 22 SHEET 1 AA1 5 LEU A 370 SER A 379 0 SHEET 2 AA1 5 THR A 384 GLN A 391 -1 O VAL A 385 N LEU A 377 SHEET 3 AA1 5 VAL A 396 ILE A 403 -1 O ILE A 403 N THR A 384 SHEET 4 AA1 5 TRP A 444 GLU A 449 -1 O MET A 448 N ALA A 400 SHEET 5 AA1 5 MET A 435 GLU A 440 -1 N ILE A 436 O VAL A 447 SHEET 1 AA2 3 GLY A 454 PRO A 455 0 SHEET 2 AA2 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA2 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA3 2 PHE A 490 VAL A 491 0 SHEET 2 AA3 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA4 2 TYR A 526 LYS A 527 0 SHEET 2 AA4 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 13 ALA A 400 GLU A 449 MET A 450 ALA A 451 SITE 2 AC1 13 GLU A 452 GLY A 454 PRO A 455 ARG A 498 SITE 3 AC1 13 ASN A 499 LEU A 501 SER A 511 ASP A 512 SITE 4 AC1 13 HOH A 837 SITE 1 AC2 4 PRO A 535 VAL A 536 LYS A 537 TRP A 538 CRYST1 39.941 85.283 90.283 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025037 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011726 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011076 0.00000